» Articles » PMID: 36767586

Oral Health-Related Quality of Life in Different Subtypes of Ehlers-Danlos Syndrome

Overview
Publisher MDPI
Date 2023 Feb 11
PMID 36767586
Authors
Affiliations
Soon will be listed here.
Abstract

This study assessed differences in the oral health-related quality of life (OHRQoL) between subtypes of Ehlers-Danlos syndrome (EDS). For statistical analysis, participants were divided according to their subtype: classical EDS (cEDS), hypermobile EDS (hEDS), and vascular EDS (vEDS). All other subtypes were descriptively analyzed. Free-text questions and the German short form of the Oral Health Impact Profile (OHIP-14) were used. Finally, 295 questionnaires were included, representing 10 different EDS subtypes. The mean OHIP score of all participants was 19.6 points (standard derivation (SD) ± 12.3). The most predominant subtypes showed similar reduced OHRQoL, with 18.0 (cEDS, ±12.9), 19.5 (hEDS, ±12.0), and 15.2 (vEDS, ±11.6) OHIP points. For all other subtypes, the OHIP values varied. Participants waited an average of 21.8 years (±12.8) for their diagnosis. However, within the predominant subtypes, vEDS patients waited a noticeably shorter period of 13.3 years (±13.0; = 0.004) compared to participants with hEDS. Additionally, this study showed no difference in OHRQoL for the predominant subtypes regardless of whether a participant was a self-help group member (18.8, ±12.0) or not (19.4, ±12.1; = ).

References
1.
Rinner A, Zschocke J, Schossig A, Grobner R, Strobl H, Kapferer-Seebacher I . High risk of peri-implant disease in periodontal Ehlers-Danlos Syndrome. A case series. Clin Oral Implants Res. 2018; 29(11):1101-1106. PMC: 6282529. DOI: 10.1111/clr.13373. View

2.
Brady A, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I . The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet. 2017; 175(1):70-115. DOI: 10.1002/ajmg.c.31550. View

3.
Mitakides J . The effect of Ehlers-Danlos syndromes on TMJ function and craniofacial pain. Cranio. 2018; 36(2):71-72. DOI: 10.1080/08869634.2018.1435092. View

4.
Cella D, Yellen S . Cancer support groups: the state of the art. Cancer Pract. 1993; 1(1):56-61. View

5.
Demmler J, Atkinson M, Reinhold E, Choy E, Lyons R, Brophy S . Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case-control comparison. BMJ Open. 2019; 9(11):e031365. PMC: 6858200. DOI: 10.1136/bmjopen-2019-031365. View